Last $57.36 USD
Change Today -0.49 / -0.85%
Volume 287.0K
ALNY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ALNYLAM PHARMACEUTICALS INC (ALNY)

Alnylam Pharmaceuticals, Inc. to Report Q1, 2014 on May 08, 2014
CapIQ 05/08/2014 4:00 AM ET
Alnylam Pharmaceuticals, Inc. to Report Q4, 2013 on Feb 13, 2014
CapIQ 05/08/2014 4:00 AM ET
Alnylam Pharmaceuticals, Inc. to Report Q3, 2013 on Nov 06, 2013
CapIQ 05/08/2014 4:00 AM ET

2013 revenues at Alnylam Pharmaceuticals, Inc. totaled $47.2M USD, while annual losses equaled $1.45 per share.

Quarterly Earnings & Estimates - ALNYLAM PHARMACEUTICALS INC (ALNY)

Actuals vs. Estimates for ALNYLAM PHARMACEUTICALS INC ALNY

Alnylam Pharmaceuticals, Inc.'s Quarterly Earnings

Alnylam Pharmaceuticals, Inc. reported 1st quarter 2014 losses of $0.39 per share on 05/10/2014.

Annual Earnings & Estimates - ALNYLAM PHARMACEUTICALS INC (ALNY)

Actuals vs. Estimates for ALNYLAM PHARMACEUTICALS INC ALNY

Alnylam Pharmaceuticals, Inc.'s Annual Earnings

Alnylam Pharmaceuticals, Inc. reported annual 2013 losses of $1.45 per share on 02/15/2014.

Quarterly Revenues - ALNYLAM PHARMACEUTICALS INC (ALNY)

Actuals vs. Estimates for ALNYLAM PHARMACEUTICALS INC ALNY

Alnylam Pharmaceuticals, Inc.'s Quarterly Revenues

Alnylam Pharmaceuticals, Inc. had 1st quarter 2014 revenues of $8.3M USD. This missed the $11.8M USD consensus estimate of the 4 analysts following the company. This was -55.6% below the prior year's 1st quarter results.

Annual Revenues - ALNYLAM PHARMACEUTICALS INC (ALNY)

Actuals vs. Estimates for ALNYLAM PHARMACEUTICALS INC ALNY

Alnylam Pharmaceuticals, Inc.'s Annual Revenues

Alnylam Pharmaceuticals, Inc. had revenues for the full year 2013 of $47.2M USD. This was -29.3% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALNY:US $57.36 USD -0.49

ALNY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Enzon Pharmaceuticals Inc $1.09 USD +0.04
Galena Biopharma Inc $2.85 USD +0.04
Regulus Therapeutics Inc $6.50 USD -0.06
Silence Therapeutics PLC 226.00 GBp -9.00
Tekmira Pharmaceuticals Corp C$11.08 CAD -0.25
View Industry Companies
 

Industry Analysis

ALNY

Industry Average

Valuation ALNY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 106.6x
Price/Book 4.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 100.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALNYLAM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.